Askpot
← Company directory

Huma: SWOT analysis

Longer, fuller lives with digital-first care and research

Strengths

  • Huma's platforms have been proven to have a sustainable impact for patients

  • can almost double clinical capacity

  • have received FDA Class II clearance

  • Huma has partnerships with major governments, hospital groups, universities, life science and technology companies

  • The product has a remote patient monitoring platform that advances connected care for patients and accelerates research and therapies.

  • The platform can almost double clinical capacity and reduce readmission rates by >30%.

  • The product supports a network of 27m patients.

  • Over 1 million devices have been shipped in support of the projects and the company knows what it takes to deploy at scale.

Weaknesses

Sign in to access Weaknesses

This content is available to registered users.

Sign in

Opportunities

Sign in to access Opportunities

This content is available to registered users.

Sign in

Threats

Sign in to access Threats

This content is available to registered users.

Sign in